BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26471806)

  • 1. Use of aminoglycoside 3' adenyltransferase as a selection marker for Chlamydia trachomatis intron-mutagenesis and in vivo intron stability.
    Lowden NM; Yeruva L; Johnson CM; Bowlin AK; Fisher DJ
    BMC Res Notes; 2015 Oct; 8():570. PubMed ID: 26471806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-specific, insertional inactivation of incA in Chlamydia trachomatis using a group II intron.
    Johnson CM; Fisher DJ
    PLoS One; 2013; 8(12):e83989. PubMed ID: 24391860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenesis of Chlamydia trachomatis Using TargeTron.
    Weber MM; Faris R
    Methods Mol Biol; 2019; 2042():165-184. PubMed ID: 31385276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transposon Mutagenesis in Chlamydia trachomatis Identifies CT339 as a ComEC Homolog Important for DNA Uptake and Lateral Gene Transfer.
    LaBrie SD; Dimond ZE; Harrison KS; Baid S; Wickstrum J; Suchland RJ; Hefty PS
    mBio; 2019 Aug; 10(4):. PubMed ID: 31387908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Group II Intron Technology for Targeted Mutagenesis in Chlamydia trachomatis.
    Key CE; Fisher DJ
    Methods Mol Biol; 2017; 1498():163-177. PubMed ID: 27709575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Functional Core of IncA Is Required for Chlamydia trachomatis Inclusion Fusion.
    Weber MM; Noriea NF; Bauler LD; Lam JL; Sager J; Wesolowski J; Paumet F; Hackstadt T
    J Bacteriol; 2016 Apr; 198(8):1347-55. PubMed ID: 26883826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Deletion by Fluorescence-Reported Allelic Exchange Mutagenesis in Chlamydia trachomatis.
    Mueller KE; Wolf K; Fields KA
    mBio; 2016 Jan; 7(1):e01817-15. PubMed ID: 26787828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of spontaneous mutations that confer antibiotic resistance in Chlamydia spp.
    Binet R; Maurelli AT
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2865-73. PubMed ID: 15980362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Floxed-Cassette Allelic Exchange Mutagenesis Enables Markerless Gene Deletion in Chlamydia trachomatis and Can Reverse Cassette-Induced Polar Effects.
    Keb G; Hayman R; Fields KA
    J Bacteriol; 2018 Dec; 200(24):. PubMed ID: 30224436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Transposon Mutagenesis for Chlamydia muridarum.
    Wang Y; LaBrie SD; Carrell SJ; Suchland RJ; Dimond ZE; Kwong F; Rockey DD; Hefty PS; Hybiske K
    J Bacteriol; 2019 Dec; 201(23):. PubMed ID: 31501283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia trachomatis and Chlamydia muridarum spectinomycin resistant vectors and a transcriptional fluorescent reporter to monitor conversion from replicative to infectious bacteria.
    Cortina ME; Ende RJ; Bishop RC; Bayne C; Derré I
    PLoS One; 2019; 14(6):e0217753. PubMed ID: 31170215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolates of Chlamydia trachomatis that occupy nonfusogenic inclusions lack IncA, a protein localized to the inclusion membrane.
    Suchland RJ; Rockey DD; Bannantine JP; Stamm WE
    Infect Immun; 2000 Jan; 68(1):360-7. PubMed ID: 10603409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the Protein Phosphatase CppA Alters Development of Chlamydia trachomatis.
    Claywell JE; Matschke LM; Plunkett KN; Fisher DJ
    J Bacteriol; 2018 Oct; 200(19):. PubMed ID: 30038048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia trachomatis ChxR is a transcriptional regulator of virulence factors that function in in vivo host-pathogen interactions.
    Yang C; Kari L; Sturdevant GL; Song L; Patton MJ; Couch CE; Ilgenfritz JM; Southern TR; Whitmire WM; Briones M; Bonner C; Grant C; Hu P; McClarty G; Caldwell HD
    Pathog Dis; 2017 Apr; 75(3):. PubMed ID: 28369275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule inhibitor of type three secretion suppresses acute and chronic Chlamydia trachomatis infection in a novel urogenital Chlamydia model.
    Koroleva EA; Kobets NV; Zayakin ES; Luyksaar SI; Shabalina LA; Zigangirova NA
    Biomed Res Int; 2015; 2015():484853. PubMed ID: 25695086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chlamydial functional homolog of KsgA confers kasugamycin sensitivity to Chlamydia trachomatis and impacts bacterial fitness.
    Binet R; Maurelli AT
    BMC Microbiol; 2009 Dec; 9():279. PubMed ID: 20043826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insertional mutagenesis in the zoonotic pathogen Chlamydia caviae.
    Filcek K; Vielfort K; Muraleedharan S; Henriksson J; Valdivia RH; Bavoil PM; Sixt BS
    PLoS One; 2019; 14(11):e0224324. PubMed ID: 31697687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of concomitant infection with Chlamydia trachomatis IncA-negative mutant and wild-type strains by genomic, transcriptional, and biological characterizations.
    Suchland RJ; Jeffrey BM; Xia M; Bhatia A; Chu HG; Rockey DD; Stamm WE
    Infect Immun; 2008 Dec; 76(12):5438-46. PubMed ID: 18852248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of pmpD expression and PmpD post-translational processing during the life cycle of Chlamydia trachomatis serovars A, D, and L2.
    Kiselev AO; Skinner MC; Lampe MF
    PLoS One; 2009; 4(4):e5191. PubMed ID: 19367336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence-Reported Allelic Exchange Mutagenesis-Mediated Gene Deletion Indicates a Requirement for Chlamydia trachomatis Tarp during
    Ghosh S; Ruelke EA; Ferrell JC; Bodero MD; Fields KA; Jewett TJ
    Infect Immun; 2020 Apr; 88(5):. PubMed ID: 32152196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.